Does the 'High Risk' Patient with Asymptomatic Carotid Stenosis Really Exist?

European Journal of Vascular and Endovascular Surgery

Volumn 35, Issue 5, 2008, Pages 524-533

  Abbott, A L ^a,b   Donnan, G A ^a,c,d  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c AUSTIN HEALTH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Asymptomatic carotid stenosis; Stroke risk

Indexed keywords

ANGIOPLASTY; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY SURGERY; CLINICAL FEATURE; CLINICAL PRACTICE; DEATH; DEMOGRAPHY; HEMATOMA; HIGH RISK PATIENT; HUMAN; INTERVENTION STUDY; MORPHOLOGY; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK; RISK FACTOR; STENT; STROKE; SURGICAL TECHNIQUE; WOUND DEHISCENCE; WOUND INFECTION;

AGED; CAROTID STENOSIS; HUMANS; MIDDLE AGED; RISK ASSESSMENT; STROKE;

EID: 41549115003     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2008.01.017     Document Type: Review

References (114)

1. Abbott A., Bladin C., Levi C., and Chambers B. What should we do with asymptomatic carotid stenosis?. Int J Stroke 2 (2007) 27-39
2. Yadav J.S., Wholey M.H., Kuntz R.E., Fayad P., Katzen B.T., Mishkel G.J., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351 (2004) 1493-1501
3. Moussa I., Rundek T., and Mohr J.E. Asymptomatic carotid artery stenosis: Risk stratification and management (2007), Informa Healthcare, London
4. Halliday A., Mansfield A., Marro J., Peto C., Peto R., Potter J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 363 (2004) 1491-1502
5. Inzitari D., Eliasziw M., Gates P., Sharpe B.L., Chan R.K., Meldrum H.E., et al. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 342 (2000) 1693-1700
6. Johnson J.M., Kennelly M.M., Decesare D., Morgan S., and Sparrow A. Natural history of asymptomatic carotid plaque. Arch Surg 120 (1985) 1010-1012
7. Chambers B.R., and Norris J.W. Outcome in patients with asymptomatic neck bruits. N Engl J Med 315 (1986) 860-865
8. Hobson II R.W., Weiss D.G., Fields W.S., Goldstone J., Moore W.S., Towne J.B., et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med 328 (1993) 221-227
9. European Carotid Surgery Trialists' Collaborative Group. Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 345 (1995) 209-212
10. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273 (1995) 1421-1428
11. Mackey A.E., Abrahamowicz M., Langlois Y., Battista R., Simard D., Bourque F., et al. Outcome of asymptomatic patients with carotid disease. Asymptomatic Cervical Bruit Study Group. Neurology 48 (1997) 896-903
12. Nicolaides A.N., Kakkos S., Griffin M., Sabetai M., Dhanjil S., Tegos T., et al. Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS Study. Eur J Vasc Endovasc Surg 30 (2005) 275-284
13. Abbott A.L., Chambers B.R., Stork J.L., Levi C.R., Bladin C.F., and Donnan G.A. Embolic signals and prediction of ipsilateral stroke or transient ischemic attack in asymptomatic carotid stenosis: a multicenter prospective cohort study. Stroke 36 (2005) 1128-1133
14. Goessens B.M., Visseren F.L., Kappelle L.J., Algra A., and van der Graaf Y. Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease: the SMART Study. Stroke 38 (2007) 1470-1475
15. Nicolaides A.N., Kakkos S., Griffin M., Geroulakos G., and Ioannidou E. Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. Eur J Vasc Endovasc Surg 31 (2006) 336
16. Bonita R., Beaglehole R., and North J.D. Event, incidence and case fatality rates of cerebrovascular disease in Auckland, New Zealand. Am J Epidemiol 120 (1984) 236-243
17. Anderson C.S., Jamrozik K.D., Burvill P.W., Chakera T.M., Johnson G.A., and Stewart-Wynne E.G. Ascertaining the true incidence of stroke: experience from the Perth Community Stroke Study, 1989-1990. Med J Aust 158 (1993) 80-84
18. Thrift A.G., Dewey H.M., Macdonell R.A., McNeil J.J., and Donnan G.A. Stroke incidence on the east coast of Australia: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 31 (2000) 2087-2092
19. Torvik A., and Joergensen L. Thrombotic and embolic occlusions of the carotid arteries in an autopsy material. I. Prevalence, location and associated diseases. J Neurol Sci 41 (1964) 24-39
20. Solberg L.A., and Eggen D.A. Localization and sequence of development of atherosclerotic lesions in the carotid and vertebral arteries. Circulation 43 (1971) 711-724
21. Hellings W.E., Pasterkamp G., Verhoeven B.A., De Kleijn D.P., De Vries J.P., Seldenrijk K.A., et al. Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy. J Vasc Surg 45 (2007) 289-296 [discussion 296-287]
22. Dick P., Sherif C., Sabeti S., Amighi J., Minar E., and Schillinger M. Gender differences in outcome of conservatively treated patients with asymptomatic high grade carotid stenosis. Stroke 36 (2005) 1178-1183
23. Hankey G.J., Slattery J.M., and Warlow C.P. Can the long term outcome of individual patients with transient ischaemic attacks be predicted accurately?. J Neurol Neurosurg Psychiatr 56 (1993) 752-759
24. Nicolaides A., Sabetai M., Kakkos S.K., Dhanjil S., Tegos T., Stevens J.M., et al. The asymptomatic carotid stenosis and risk of stroke (ACSRS) study. Aims and results of quality control. Int Angiol 22 (2003) 263-272
25. Wald N.J., and Law M.R. A strategy to reduce cardiovascular disease by more than 80%. BMJ 326 (2003) 1419
26. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 337 (1991) 1235-1243
27. Corrado E., Rizzo M., Tantillo R., Muratori I., Bonura F., Vitale G., et al. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke 37 (2006) 482-486
28. Daskalopoulou S.S., Daskalopoulos M.E., Perrea D., Nicolaides A.N., and Liapis C.D. Carotid artery atherosclerosis: what is the evidence for drug action?. Curr Pharm Des 13 (2007) 1141-1159
29. Oei H.H., van der Meer I.M., Hofman A., Koudstaal P.J., Stijnen T., Breteler M.M., et al. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation 111 (2005) 570-575
30. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., and Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337 (1997) 230-236
31. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325 (2002) 1202
32. VITATOPS Trial Study Group. The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovasc Dis 13 (2002) 120-126
33. AbuRahma A.F., Cook C.C., Metz M.J., Wulu Jr. J.T., and Bartolucci A. Natural history of carotid artery stenosis contralateral to endarterectomy: results from two randomized prospective trials. J Vasc Surg 38 (2003) 1154-1161
34. Golemati S., Sassano A., Lever M.J., Bharath A.A., Dhanjil S., and Nicolaides A.N. Carotid artery wall motion estimated from B-mode ultrasound using region tracking and block matching. Ultrasound Med Biol 29 (2003) 387-399
35. Bock R.W., Gray-Weale A.C., Mock P.A., App Stats M., Robinson D.A., Irwig L., et al. The natural history of asymptomatic carotid artery disease. J Vasc Surg 17 (1993) 160-169 [discussion 170-171]
36. Carra G., Visona A., Bonanome A., Lusiani L., Pesavento R., Bortolon M., et al. Carotid plaque morphology and cerebrovascular events. Int Angiol 22 (2003) 284-289
37. Kitamura A., Iso H., Imano H., Ohira T., Okada T., Sato S., et al. Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men. Stroke 35 (2004) 2788-2794
38. Prabhakaran S., Rundek T., Ramas R., Elkind M.S., Paik M.C., Boden-Albala B., et al. Carotid plaque surface irregularity predicts ischemic stroke: the Northern Manhattan Study. Stroke 37 (2006) 2696-2701
39. Sterpetti A.V., Schultz R.D., Feldhaus R.J., Davenport K.L., Richardson M., Farina C., et al. Ultrasonographic features of carotid plaque and the risk of subsequent neurologic deficits. Surgery 104 (1988) 652-660
40. Langsfeld M., Gray-Weale A.C., and Lusby R.J. The role of plaque morphology and diameter reduction in the development of new symptoms in asymptomatic carotid arteries. J Vasc Surg 9 (1989) 548-557
41. Belcaro G., Laurora G., Cesarone M.R., De Sanctis M.T., Incandela L., Fascetti E., et al. Ultrasonic classification of carotid plaques causing less than 60% stenosis according to ultrasound morphology and events. J Cardiovasc Surg (Torino) 34 (1993) 287-294
42. Polak J.F., O'Leary D.H., Kronmal R.A., Wolfson S.K., Bond M.G., Tracy R.P., et al. Sonographic evaluation of carotid artery atherosclerosis in the elderly: relationship of disease severity to stroke and transient ischemic attack. Radiology 188 (1993) 363-370
43. Nicolaides A.N., Kakkos S.K., Griffin M., Sabetai M., Dhanjil S., Thomas D.J., et al. Effect of image normalization on carotid plaque classification and the risk of ipsilateral hemispheric ischemic events: results from the Asymptomatic Carotid Stenosis and Risk of Stroke Study. Vascular 13 (2005) 211-221
44. Hennerici M., and Meairs S. Imaging arterial wall disease. Cerebrovasc Dis 10 Suppl. 5 (2000) 9-20
45. Schumacher H., Kaiser E., Schnabel P.A., Sykora J., Eckstein H.H., and Allenberg J.R. Immunophenotypic characterisation of carotid plaque: increased amount of inflammatory cells as an independent predictor for ischaemic symptoms. Eur J Vasc Endovasc Surg 21 (2001) 494-501
46. Davies J.R., Rudd J.H., Weissberg P.L., and Narula J. Radionuclide imaging for the detection of inflammation in vulnerable plaques. J Am Coll Cardiol 47 (2006) C57-C68
47. Fisher C.M., and Ojemann R.G. A clinico-pathologic study of carotid endarterectomy plaques. Rev Neurol (Paris) 142 (1986) 573-589
48. Bassiouny H.S., Davis H., Massawa N., Gewertz B.L., Glagov S., and Zarins C.K. Critical carotid stenoses: morphologic and chemical similarity between symptomatic and asymptomatic plaques. J Vasc Surg 9 (1989) 202-212
49. Svindland A., and Torvik A. Atherosclerotic carotid disease in asymptomatic individuals: an histological study of 53 cases. Acta Neurol Scand 78 (1988) 506-517
50. Golledge J., Greenhalgh R.M., and Davies A.H. The symptomatic carotid plaque. Stroke 31 (2000) 774-781
51. Fisher M., Paganini-Hill A., Martin A., Cosgrove M., Toole J.F., Barnett H.J., et al. Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke 36 (2005) 253-257
52. Lennihan L., Kupsky W.J., Mohr J.P., Hauser W.A., Correll J.W., and Quest D.O. Lack of association between carotid plaque hematoma and ischemic cerebral symptoms. Stroke 18 (1987) 879-881
53. Rothwell P.M., Gibson R., and Warlow C.P. Interrelation between plaque surface morphology and degree of stenosis on carotid angiograms and the risk of ischemic stroke in patients with symptomatic carotid stenosis. On behalf of the European Carotid Surgery Trialists' Collaborative Group. Stroke 31 (2000) 615-621
54. Leahy A.L., McCollum P.T., Feeley T.M., Sugrue M., Grouden M.C., O'Connell D.J., et al. Duplex ultrasonography and selection of patients for carotid endarterectomy: plaque morphology or luminal narrowing?. J Vasc Surg 8 (1988) 558-562
55. Abbott AL. Natural history of high-grade asymptomatic carotid stenosis and identification of high ipsilateral stroke or TIA risk using microembolus detection. Thesis, The University of Melbourne, Department of Medicine; 2004. p. 438.
56. Abbott A.L., Levi C.R., Stork J.L., Donnan G.A., and Chambers B.R. Timing of clinically significant microembolism after carotid endarterectomy. Cerebrovasc Dis 23 (2007) 362-367
57. Spence J.D., Tamayo A., Lownie S.P., Ng W.P., and Ferguson G.G. Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke 36 (2005) 2373-2378
58. Markus H.S., and Cullinane M. Asymptomatic carotid emboli (ACES) study. Cerebrovasc Dis 10 Suppl. 1 (2000) 3
59. Markus H., and Cullinane M. Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain 124 (2001) 457-467
60. Derdeyn C.P., Grubb Jr. R.L., and Powers W.J. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology 53 (1999) 251-259
61. 1H-MR spectroscopic imaging study. Stroke 26 (1995) 822-828
62. Norris J.W., and Zhu C.Z. Silent stroke and carotid stenosis. Stroke 23 (1992) 483-485
63. Chambers B.R., and Donnan G.A. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev (2005) CD001923
64. Beebe H.G., Clagett G.P., DeWeese J.A., Moore W.S., Robertson J.T., Sandok B., et al. Assessing risk associated with carotid endarterectomy. A statement for health professionals by an ad hoc committee on carotid surgery standards of the Stroke Council, American Heart Association. Circulation 79 (1989) 472-473
65. Young B., Moore W.S., Robertson J.T., Toole J.F., Ernst C.B., Cohen S.N., et al. An analysis of perioperative surgical mortality and morbidity in the Asymptomatic Carotid Atherosclerosis Study. ACAS investigators. Stroke 27 (1996) 2216-2224
66. Goldstein L.B., Adams R., Becker K., Furberg C.D., Gorelick P.B., Hademenos G., et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 32 (2001) 280-299
67. Goldstein L.B., Adams R., Becker K., Furberg C.D., Gorelick P.B., Hademenos G., et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 103 (2001) 163-182
68. Wennberg D.E., Lucas F.L., Birkmeyer J.D., Bredenberg C.E., and Fisher E.S. Variation in carotid endarterectomy mortality in the Medicare population: Trial hospitals, volume, and patient characteristics. JAMA 279 (1998) 1278-1281
69. Taylor D.W., Barnett H.J., Haynes R.B., Ferguson G.G., Sackett D.L., Thorpe K.E., et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and carotid endarterectomy (ACE) Trial Collaborators. Lancet 353 (1999) 2179-2184
70. Bond R., Rerkasem K., and Rothwell P. High morbidity and mortality due to endarterectomy for asymptomatic carotid stenosis (abs). Cerebrovasc Dis 16 Suppl. 4 (2003) 65-66
71. Rothwell P.M., and Goldstein L.B. Carotid endarterectomy for asymptomatic carotid stenosis: Asymptomatic Carotid Surgery Trial. Stroke 35 (2004) 2425-2427
72. Kresowik T.F., Bratzler D.W., Kresowik R.A., Hendel M.E., Grund S.L., Brown K.R., et al. Multistate improvement in process and outcomes of carotid endarterectomy. J Vasc Surg 39 (2004) 372-380
73. Gray W.A., Hopkins L.N., Yadav S., Davis T., Wholey M., Atkinson R., et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg 44 (2006) 258-268
74. Safian R.D., Bresnahan J.F., Jaff M.R., Foster M., Bacharach J.M., Maini B., et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol 47 (2006) 2384-2389
75. Hobson II R.W., Howard V.J., Roubin G.S., Brott T.G., Ferguson R.D., Popma J.J., et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 40 (2004) 1106-1111
76. CaRESS Steering Committee. Carotid revascularization using endarterectomy or stenting systems (CaRESS) phase 1 clinical trial: 1-year results. J Vasc Surg 42 (2005) 213-219
77. Katzen B.T. The Transatlantic Asymptomatic Carotid Intervention Trial. Endovascular Today (2005 September) 49-50
78. CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 357 (2001) 1729-1737
79. Mas J.L., Chatellier G., Beyssen B., Branchereau A., Moulin T., Becquemin J.P., et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 355 (2006) 1660-1671
80. Ringleb P.A., Allenberg J., Bruckmann H., Eckstein H.H., Fraedrich G., Hartmann M., et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 368 (2006) 1239-1247
81. Naylor A.R. Where next after SPACE and EVA-3s: 'the good, the bad and the ugly!'. Eur J Vasc Endovasc Surg 33 (2007) 44-47
82. Rothwell P.M., Eliasziw M., Gutnikov S.A., Fox A.J., Taylor D.W., Mayberg M.R., et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 361 (2003) 107-116
83. Mayberg M.R., Wilson S.E., Yatsu F., Weiss D.G., Messina L., Hershey L.A., et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA 266 (1991) 3289-3294
84. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 (1991) 445-453
85. Coward L.J., Featherstone R.L., and Brown M.M. Safety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence. Stroke 36 (2005) 905-911
86. Rothwell P.M., Slattery J., and Warlow C.P. A systematic comparison of the risks of stroke and death due to carotid endarterectomy for symptomatic and asymptomatic stenosis. Stroke 27 (1996) 266-269
87. Role of carotid endarterectomy in asymptomatic carotid stenosis. A Veterans Administration Cooperative Study. Stroke 17 (1986) 534-539
88. Goldstein L.B., Samsa G.P., Matchar D.B., and Oddone E.Z. Multicenter review of preoperative risk factors for endarterectomy for asymptomatic carotid artery stenosis. Stroke 29 (1998) 750-753
89. Baker W.H., Howard V.J., Howard G., and Toole J.F. Effect of contralateral occlusion on long-term efficacy of endarterectomy in the asymptomatic carotid atherosclerosis study (ACAS). ACAS investigators. Stroke 31 (2000) 2330-2334
90. Rothwell P.M., Slattery J., and Warlow C.P. Clinical and angiographic predictors of stroke and death from carotid endarterectomy: systematic review. BMJ 315 (1997) 1571-1577
91. Miller M.T., Comerota A.J., Tzilinis A., Daoud Y., and Hammerling J. Carotid endarterectomy in octogenarians: does increased age indicate "High risk?". J Vasc Surg 41 (2005) 231-237
92. Bond R., Rerkasem K., Cuffe R., and Rothwell P.M. A systematic review of the associations between age and sex and the operative risks of carotid endarterectomy. Cerebrovasc Dis 20 (2005) 69-77
93. Veith F.J., Amor M., Ohki T., Beebe H.G., Bell P.R., Bolia A., et al. Current status of carotid bifurcation angioplasty and stenting based on a consensus of opinion leaders. J Vasc Surg 33 (2001) S111-S116
94. Messe S.R., Kasner S.E., Mehta Z., Warlow C.P., and Rothwell P.M. Effect of body size on operative risk of carotid endarterectomy. J Neurol Neurosurg Psychiatr 75 (2004) 1759-1761
95. Kucey D.S., Bowyer B., Iron K., Austin P., Anderson G., and Tu J.V. Determinants of outcome after carotid endarterectomy. J Vasc Surg 28 (1998) 1051-1058
96. Hertzer N.R., O'Hara P.J., Mascha E.J., Krajewski L.P., Sullivan T.M., and Beven E.G. Early outcome assessment for 2228 consecutive carotid endarterectomy procedures: the Cleveland Clinic experience from 1989 to 1995. J Vasc Surg 26 (1997) 1-10
97. Wong J.H., Findlay J.M., and Suarez-Almazor M.E. Regional performance of carotid endarterectomy. Appropriateness, outcomes, and risk factors for complications. Stroke 28 (1997) 891-898
98. Biasi G.M., Froio A., Diethrich E.B., Deleo G., Galimberti S., Mingazzini P., et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting: the imaging in carotid angioplasty and risk of stroke (ICAROS) Study. Circulation 110 (2004) 756-762
99. Moore W.S., Vescera C.L., Robertson J.T., Baker W.H., Howard V.J., and Toole J.F. Selection process for surgeons in the Asymptomatic Carotid Atherosclerosis Study. Stroke 22 (1991) 1353-1357
100. Halliday A.W., Thomas D., and Mansfield A. The Asymptomatic Carotid Surgery Trial (ACST). Rationale and design. Steering Committee. Eur J Vasc Surg 8 (1994) 703-710
101. Rubin J.R., Pitluk H.C., King T.A., Hutton M., Kieger E.F., Plecha F.R., et al. Carotid endarterectomy in a metropolitan community: the early results after 8535 operations. J Vasc Surg 7 (1988) 256-260
102. Kantonen I., Lepantalo M., Salenius J.P., Matzke S., Luther M., and Ylonen K. Influence of surgical experience on the results of carotid surgery. The Finnvasc Study Group. Eur J Vasc Endovasc Surg 15 (1998) 155-160
103. Karp H.R., Flanders W.D., Shipp C.C., Taylor B., and Martin D. Carotid endarterectomy among Medicare beneficiaries: a statewide evaluation of appropriateness and outcome. Stroke 29 (1998) 46-52
104. Cebul R.D., Snow R.J., Pine R., Hertzer N.R., and Norris D.G. Indications, outcomes and provider volumes for carotid endarterectomy. JAMA 279 (1998) 1282-1287
105. Hsia D.C., Moscoe L.M., and Krushat W.M. Epidemiology of carotid endarterectomy among Medicare beneficiaries: 1985-1996 update. Stroke 29 (1998) 346-350
106. Hannan E.L., Popp A.J., Tranmer B., Fuestel P., Waldman J., and Shah D. Relationship between provider volume and mortality for carotid endarterectomies in New York State. Stroke 29 (1998) 2292-2297
107. Mayo Asymptomatic Carotid Endarectomy Study Group. Results of a randomized controlled trial of carotid endarterectomy for asymptomatic carotid stenosis. Mayo Clin Proc 67 (1992) 513-518
108. Lindblad B., Persson N.H., Takolander R., and Bergqvist D. Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial. Stroke 24 (1993) 1125-1128
109. Rothwell P., and Warlow C. Is self-audit reliable?. Lancet 346 (1995) 1623
110. Theiss W., Hermanek P., Mathias K., Ahmadi R., Heuser L., Hoffmann F.J., et al. Pro-cas: a prospective registry of carotid angioplasty and stenting. Stroke 35 (2004) 2134-2139
111. Sacco R.L. The 2006 William Feinberg Lecture: shifting the paradigm from stroke to global vascular risk estimation. Stroke 38 (2007) 1980-1987
112. Chaturvedi S. Should the multicenter carotid endarterectomy trials be repeated?. Arch Neurol 60 (2003) 774-775
113. Gorelick P.B. Stroke prevention. Arch Neurol 52 (1995) 347-355
114. Spence J.D. Intensive management of risk factors for accelerated atherosclerosis: The role of multiple interventions. Curr Neurol Neurosci Rep 7 (2007) 42-48